Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib
Klaihmon, Phatchanat, Lorthongpanich, Chanchao, Kheolamai, Pakpoom, Saisaard, Wannachai, Issaragrisil, Surapol
Published in Scientific reports (18.02.2024)
Published in Scientific reports (18.02.2024)
Get full text
Journal Article
Comparative analysis of BCR::ABL1 p210 mRNA transcript quantification and ratio to ABL1 control gene converted to the International Scale by chip digital PCR and droplet digital PCR for monitoring patients with chronic myeloid leukemia
Saisaard, Wannachai, Owattanapanich, Weerapat
Published in Clinical chemistry and laboratory medicine (20.08.2024)
Published in Clinical chemistry and laboratory medicine (20.08.2024)
Get full text
Journal Article